Point72 Asset Management’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,230,377
Closed -$53.4M 2295
2025
Q2
$53.4M Buy
1,230,377
+837,889
+213% +$31.9M 0.1% 239
2025
Q1
$14.7M Buy
392,488
+89,753
+30% +$3.47M 0.03% 544
2024
Q4
$13.7M Sell
302,735
-404,533
-57% -$20.6M 0.03% 592
2024
Q3
$41.5M Buy
707,268
+438,036
+163% +$21M 0.11% 226
2024
Q2
$10.6M Sell
269,232
-217,968
-45% -$10.6M 0.03% 594
2024
Q1
$32.4M Sell
487,200
-221,200
-31% -$9.66M 0.08% 307
2023
Q4
$19.8M Buy
708,400
+335,292
+90% +$6.72M 0.05% 427
2023
Q3
$7.95M Buy
+373,108
New +$8.22M 0.02% 727

Other funds holding APGE